Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA accepts for review sBLA for Keytruda in advanced NSCLC

June 2, 2015

Amgen and Merck & Co. expand immunotherapy collaboration

June 2, 2015

Lilly and AstraZeneca enter clinical trial collaboration to study MEDI-4736 with ramucirumab

June 2, 2015

University of Montpellier and INSERM jointly patent new HER3 antibodies

May 29, 2015

ADC Therapeutics and LivTech sign antibody license agreement

May 28, 2015

Lipo-MERIT: a novel tetravalent RNA cancer vaccine

May 26, 2015

Nivolumab receives EMA recommendation for squamous NSCLC

May 25, 2015

EMA committee hands down positive opinion for Keytruda in advanced melanoma

May 25, 2015

U.S. scientists report anti-EFNA4 antibody-drug conjugates

May 25, 2015

OncoSec funds preclinical research into ImmunoPulse IL-12 in HPV-related cancer

May 21, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...